Tyra Biosciences, Inc.TYRANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank50
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-13.06
↑ 80% vs avg
Percentile
P50
Within normal range
Streak
3 yr
Consecutive declineElevated
Average
-64.29
Historical baseline
PeriodValueYoY Change
2025-13.06-42.0%
2024-9.20-7.5%
2023-8.56-48.7%
2022-5.75+74.1%
2021-22.18+81.3%
2020-118.74+56.4%
2019-272.53-